These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 17154507)
1. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. Muller P; Lena G; Boilard E; Bezzine S; Lambeau G; Guichard G; Rognan D J Med Chem; 2006 Nov; 49(23):6768-78. PubMed ID: 17154507 [TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors. Gopalsamy A; Yang H; Ellingboe JW; McKew JC; Tam S; Joseph-McCarthy D; Zhang W; Shen M; Clark JD Bioorg Med Chem Lett; 2006 Jun; 16(11):2978-81. PubMed ID: 16545564 [TBL] [Abstract][Full Text] [Related]
3. 1,3,5-Triazepan-2,6-diones as conformationally constrained dipeptide mimetics. In silico guided identification of sPLA2 inhibitors. Guichard G; Léna G; Boeglin J; Muller P; Boilard E; Lambeau G; Rognan D; Didierjean C Adv Exp Med Biol; 2009; 611():201-2. PubMed ID: 19400159 [No Abstract] [Full Text] [Related]
4. RASSE: a new method for structure-based drug design. Luo Z; Wang R; Lai L J Chem Inf Comput Sci; 1996; 36(6):1187-94. PubMed ID: 8941995 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and target identification of hymenialdisine analogs. Wan Y; Hur W; Cho CY; Liu Y; Adrian FJ; Lozach O; Bach S; Mayer T; Fabbro D; Meijer L; Gray NS Chem Biol; 2004 Feb; 11(2):247-59. PubMed ID: 15123286 [TBL] [Abstract][Full Text] [Related]
6. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives. Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154 [TBL] [Abstract][Full Text] [Related]
7. 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Boyd HF; Flynn ST; Hickey DM; Ife RJ; Jones M; Leach CA; Macphee CH; Milliner KJ; Rawlings DA; Slingsby BP; Smith SA; Stansfield IG; Tew DG; Theobald CJ Bioorg Med Chem Lett; 2000 Feb; 10(4):395-8. PubMed ID: 10714508 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug design. Tanaka T; Sugawara H; Maruoka H; Imajo S; Muto T Bioorg Med Chem; 2013 Jul; 21(14):4233-49. PubMed ID: 23719288 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis of lipophilic keto acids by acylation of alkylbenzenes as potential inhibitors of phospholipase A2]. Nuhn P; Radman M; Hermann A; Marx K Pharmazie; 1998 Dec; 53(12):825-9. PubMed ID: 10189306 [No Abstract] [Full Text] [Related]